Table 1.
Pharmacological agent | Chemical structure | Source | Autophagy-associated targets | Mechanism of action | References |
Activators | |||||
Rapamycin (Sirolimus) | Macrocyclic lactone | Streptomyces hygroscopicus | mTOR | Inhibits mTORC1 (acute and chronic exposure) Inhibits mTORC2 (chronic exposure) Rapamycin binds FKBP12 and act as an allosteric inhibitor |
(148) |
Temsirolimus | Derivative of rapamycin | Synthetic analog of rapamycin | (149) | ||
Everolimus (RAD-001) | Derivative of rapamycin | Synthetic analog of rapamycin | (150) | ||
Erlotinib | Quinazolinamine | Synthetic compound | EGFR | Inhibition of the EGFR signaling by interaction with ATP binding site | (151) |
Imatinib | 2-phenyl amino pyrimidine | Synthetic drug | BCR-ABL c-Abl Abl-related gene |
Inhibits selectively tyrosine kinases Sequestering of the Bcr-Abl protein into autophagosomes |
(152,153) |
Dasatinib (BMS-354825) | Derivative of aminopyrimidine | Synthetic compound | Src/Abl family kinases | Reduces the phosphorylation of AKT, mTOR, p70S6K, and S6 kinase expression Requires BECN1 and ATG12 |
(154,155) |
Vorinostat (SAHA) | Hydroxamic acid derivative | Synthetic compound | HDAC | Acetylation of ATG proteins leading to hyperactivation of PIK3C3 Upregulation of LC3 Inhibition of mTOR |
(156-158) |
Arsenic Trioxide | Amphoteric oxide | Processing of the mineral arsenic | TFEB ROS PI3K/AKT/mTOR |
Nuclear translocation of TFEB Inhibition of PI3K/AKT/mTOR pathway Generation of ROS |
(159) |
Epigallocatechin-3-gallate* | Polyphenol. | Green tea leaves | mTOR-AMPK | Induces activation of AMPK and inhibition of mTOR | (160,161) |
Polygonatum cyrtonema lectin* | Lectin | Rhizomes of Polygonatum cyrtonema | Mitochondria-mediated ROS-p38-p53 pathway | Accumulation of mitochondrial ROS, activating p38 and p53 | (162,163) |
Spermidine* | Polyamine | Dry soy bean, chicken liver, green peas, corn, shell fish, and blue cheese | Acetylation of histones | Modifies epigenetic landscape Increases the expression of ATG |
(164,165) |
Resveratrol* | Polyphenol | Grapes, apples, plums, blueberries, and peanut | mTOR, AMPK, SIRT1 | Inhibiting mTOR via several routes, activates AMPK and SIRT1 | (166-168) |
Allicin* | Sulfoxide | Allium sativum | p53, mTOR and AMPK | Modulation of the pathways leading to autophagy | (169,170) |
Ginsenosides* | Saponins | Ginseng root | Autophagy-related pathways | Modulation of the pathways leading to autophagy | (171,172) |
Curcumin* | Diarylheptanoid | Curcuma longa | ROS mTOR |
Inhibiition of mTOR Overexpression of autophagy-related proteins |
(173-175) |
Pharmacological agent | Chemical structure | Source | Molecular target | Mechanism of action | References |
Inhibitors | |||||
Wortmannin | Furanosteroid | Penicillium funiculosum Talaromyces wortmannii | PI3KC1 (transient) PI3KC3 (persistent) |
Inhibition of the production of PIP3 | (146) |
3-Methyladenin | Adenin | Saccharomyces cerevisiae | PI3KC1 (persistent) PI3KC3 (transient) |
Inhibition of PI3K Promotion of autophagic flux under nutrient-rich conditions (dual role) |
(176,177) |
Chloroquine | Aminoquinoline | Cinchona officinalis | Lysosomal pH SNAP29? |
Slows down lysosomal acidification Inhibition of the fusion of autophagosomes with lysosomes |
(178,179) |
Pepstatin-A | Hexapeptide | Streptomyces sp | Cathepsin D and E | Inhibition of lysosomal proteases Accumulation of LC3-II |
(146,180) |
Bafilomycin A1 | Macrolide | Streptomyces sp | Vacuolar-ATPase SERCA |
Reduce lysosomal acidification Disrupt autophagosome-lysosome fusion |
(181,182) |
Hydroxy-chloroquine | Derivate from chloroquine | Synthetic modification of cloroquine | Lysosomal pH | Slows down lysosomal acidification Inhibition of the fusion of autophagosomes with lysosomes |
(183,184) |
Spautin-1 | 4-quinazolinamine | Synthetic compound | Ubiquitin-specific peptidase 10 and 13 | Inhibits autophagy by the degradation of PI3K3 and BECN1 | (185,186) |
SAR405 | Pyrimidine | Small molecule inhibitor | Class III PI3K | A selective ATP-competitive inhibitor of PI3K class III | (187) |
siRNAs | 20 to 24-bp double-stranded RNA | Synthetic compound | ATG mRNA | Knockdown the autophagy machinery, e.g.: ATG5 | (188,189) |